Average Co-Inventor Count = 4.36
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eisai Inc. (8 from 33 patents)
2. Mgi Gp, Inc. (3 from 7 patents)
3. Guilford Pharmaceuticals, Inc. (2 from 98 patents)
4. Eisai Corporation of North America (1 from 4 patents)
14 patents:
1. 8894989 - PARP inhibitor compounds, compositions and methods of use
2. 8883787 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
3. 8470825 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
4. 8236802 - PARP inhibitor compounds, compositions and methods of use
5. 8129382 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
6. 8058275 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
7. 7820668 - Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP
8. 7750008 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
9. 7601719 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
10. 7456178 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
11. 7268138 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
12. 7247641 - Compounds, derivatives, compositions, preparation and uses
13. 6884907 - Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
14. 6635786 - Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use